Differentiation of equine induced pluripotent stem cells into a keratinocyte lineage. (29th May 2015)

• Record Type: Journal Article
• Authors: Aguiar, C.; Therrien, J.; Lemire, P.; Segura, M.; Smith, L. C.; Theoret, C. L.
• Is Part Of: Equine veterinary journal. Volume 48:Number 3(2016:May)
• Page Start: 338
• Page End: 345
• Publication Date: 2015-05-29
• Subjects: horse -- induced pluripotent stem cells -- keratinocytes -- wound healing -- regenerative medicine; Horses -- Diseases -- Periodicals; 636.108905
• DOI: 10.1111/evj.12438
• Languages: English
• ISSNs: 0425-1644

Abstract

Summary: Reasons for performing study: Skin trauma in horses often leads to the development of chronic nonhealing wounds that lack a keratinocyte cover, vital for healing. Reports in mouse and man confirm the possibility of generating functional keratinocytes from induced pluripotent stem cells (iPSC), thus presenting myriad potential applications for wound management or treatment of skin disease. Similarly, differentiation of equine iPSC (eiPSC) into a keratinocyte lineage should provide opportunities for the advancement of veterinary regenerative medicine. Objectives: The purpose of this study was to develop an efficient method for the differentiation of eiPSC into a keratinocyte lineage. It was hypothesised that eiPSC can form differentiated keratinocytes (eiPSC‐KC) comparable with primary equine keratinocytes (PEK) in their morphological and functional characteristics. Study design: Experimental in vitro study. Methods: Equine iPSC established using a nonviral system were treated for 30 days with retinoic acid and bone morphogenetic protein‐4 to induce directed differentiation into iPSC‐KC. Temporospatial gene and protein expression by eiPSC‐KC was measured at weekly intervals of differentiation and in response to calcium switch. Proliferative and migratory capacities of eiPSC‐KC were compared with those of PEK. Results: Equine iPSC, upon directed differentiation, showed loss of pluripotency genes and progressive increase in pancytokeratin expression indicating ectodermal specification into keratinocytes. High differentiation efficiency was achieved, with 82.5% of eiPSC expressing keratin 14, a marker of epidermal‐specific basal stem cells, after 30 days of directed differentiation. Moreover, the proliferative capacity of eiPSC‐KC was superior, while the migratory capacity (measured as the ability to epithelise in vitro wounds) was comparable with that of PEK. Conclusions: This proof of concept study suggests that eiPSC can successfully be differentiated into equine keratinocytes (eiPSC‐KC) with features that are promising to the development of a stem cell‐based skin construct, with the potential to regenerate lost or damaged skin.